Alkali Metal Or Alkaline Earth Containing Patents (Class 424/722)
-
Publication number: 20130058954Abstract: The present invention relates to methods of diagnosis and treatment of corneal ectasia following refractive surgery, keratoconus or pellucid marginal degeneration in a subject by determining or modulating the level of expression of molecules associated with the Wnt signalling pathway. Marker molecules of the present invention include SFRP1, PITX2, LEF1, WNT16 and WNT5A.Type: ApplicationFiled: December 2, 2010Publication date: March 7, 2013Applicant: THE UNIVERSITY OF SYDNEYInventors: Gerard Sutton, John McAvoy, Michele Madigan
-
Publication number: 20130052280Abstract: The use of theobromine for lowering central blood pressure and/or lowering central pulse pressure in humans and derived benefits, and compositions comprising theobromine.Type: ApplicationFiled: January 18, 2011Publication date: February 28, 2013Inventors: Richard Draijer, Bas Van Den Bogaard
-
Publication number: 20130052248Abstract: An item of clothing (10) for daily pharmacological treatment of a fungal infection, comprising: a textile material (20) to manage moisture when the item of clothing (10) is worn; microcapsules (30) grafted on the textile material (20); and antifungal agents encapsulated within the microcapsules (30) to pharmacologically treat the fungal infection when released from the microcapsules (30).Type: ApplicationFiled: August 26, 2011Publication date: February 28, 2013Inventors: Marcus Chun Wah YUEN, Joanne Yiu Wan YIP, Kevin CHEUK, Chi Wai KAN, Shuk Yan CHENG
-
Publication number: 20130052281Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.Type: ApplicationFiled: August 22, 2012Publication date: February 28, 2013Applicant: Takeda Pharmaceutical Company LimitedInventors: William FARNABY, Charlotte FIELDHOUSE, Catrina KERR, Natasha KINSELLA, David LIVERMORE, Kevin MERCHANT, David MILLER, Katherine HAZEL
-
Publication number: 20130045183Abstract: The present disclosure relates to non-acidic extracts or fractions selected from a Boswellia low polar gum resin extract fraction (BLPRE), a Boswellia volatile oil fraction (BVOIL), and a Boswellia oil fraction (BOIL) and their compositions. BLPRE, BOIL, and BVOIL are each derived from the gum resin of a Boswellia species. These compositions are useful for improving mental condition, enhancing brain functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases. Additionally, BOIL, BVOIL, and mixtures of BOIL and BVOIL are useful for enhancing the bioavailability of a biological agent.Type: ApplicationFiled: September 14, 2012Publication date: February 21, 2013Applicant: LAILA NUTRACEUTICALSInventors: Ganga Raju GOKARAJU, Rama Raju GOKARAJU, Venkata Kanaka Ranga Raju GOKARAJU, Trimurtulu GOLAKOTI, Kiran BHUPATHIRAJU, Venkata Krishna Raju ALLURI
-
Publication number: 20130045247Abstract: The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating fatty acids to quetiapine. Pharmaceutical compositions and methods of synthesizing conjugates of the present technology are also provided. Methods of treating patients with the compositions of the present technology are also provided.Type: ApplicationFiled: March 9, 2011Publication date: February 21, 2013Inventors: Travis Mickle, Sven Guenther, Sanjib Bera
-
Patent number: 8372444Abstract: A composition comprises an ion-exchanged carrageenan. The carrageenan may be a traditionally extracted or neutrally extracted iota or kappa carrageenan. The ion-exchanged carrageenan has reduced gelling cation contents, reduced gelling temperature, and reduced melting temperature, as compared to its non-ion-exchanged counterpart. The ion-exchanged carrageenan may be mixed with another carrageenan to form a carrageenan product having a unique gelling temperature and melting temperature. Also disclosed is a process for making an ion-exchanged carrageenan composition.Type: GrantFiled: September 5, 2012Date of Patent: February 12, 2013Assignee: CP Kelco U.S., Inc.Inventor: Jens Eskil Trudsoe
-
Publication number: 20130004594Abstract: Disclosed are oral rehydration compositions with sucrose, or alternatively fructose and glucose in a 1:1 ratio. The composition further comprises an osmolarity of below 250 mOsm/L, and sodium below 75 meq/L. Further disclosed are methods of treatment using the same.Type: ApplicationFiled: July 1, 2011Publication date: January 3, 2013Applicant: Drip Drop, Inc.Inventor: Eduardo P. Dolhun
-
Publication number: 20130004588Abstract: Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste. The methods employ the topical application of a trypsin-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The trypsin-inhibiting agent is preferably a divalent cation.Type: ApplicationFiled: June 28, 2011Publication date: January 3, 2013Inventors: Connie B. Lin, Euen Thomas Graham Ekman Gunn, Ya-Ping Hu, Neema Kulkarni, Mary Catherine Mack
-
Publication number: 20120321725Abstract: Provided is a method of preparing a red clay processed material using red clay and sodium hydroxide and a red clay processed material having anti-corrosive and virus disinfecting activity. Also, a method of preparing alkali ionized water having excellent anti-bacterial, virus disinfecting and anti-corrosive activity using the red clay processed material, alkali ionized water using the same, and a functional product including the same are provided. The red clay processed material and the method of preparing alkali ionized water using the same can reduce the reaction temperature and reaction time compared to a conventional process, thereby significantly reducing the production cost.Type: ApplicationFiled: February 3, 2010Publication date: December 20, 2012Applicant: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Jung-Keug Park, Moon Young Yoon
-
Publication number: 20120315310Abstract: The present invention is based on that local administration of lithium ions in bone tissue has been found to improve the bone formation and bone mass upon implantation of a bone tissue implant in said bone tissue. In particular, the invention relates to a bone tissue implant having an implant surface covered by an oxide layer comprising lithium ions and a method for the manufacture thereof. A blasting powder comprising lithium ions, a method for locally increasing bone formation, and the use of lithium ions or a salt thereof for manufacturing a pharmaceutical composition for locally increasing bone formation are also provided by the present invention.Type: ApplicationFiled: August 21, 2012Publication date: December 13, 2012Applicant: Astra Tech ABInventors: Stig HANSSON, Ingela Petersson
-
Patent number: 8329227Abstract: The present invention provides formulas for producing compositions for the structural/functional nutritional support for those who struggle with poor focus, concentration and/or memory. In addition, the present invention provides compositions comprising nutritional/botanical factors helpful to those who subjectively experience transient mental fatigue or poor cognitive function. The compositions of this invention consist primarily of the following ingredients B-complex vitamins, antioxidants, minerals, phosphatidyl serine (PS), choline, dimenthyl-aminoethanol (DMAE), docosahexaenoic acid (DHA), L-pyroglutamic acid, as well as herbal extracts from Bacopa monniera, Vinca minor, and Huperzia serrata. The present invention also relates to the administration of these compounds to alleviate mental fatigue or poor cognitive function.Type: GrantFiled: December 7, 2004Date of Patent: December 11, 2012Assignee: Factor Nutrition Labs, LLCInventor: Kyl L. Smith
-
Patent number: 8332028Abstract: This invention provides new and novel devices and methods for administering lithium (Li) ions to a mammalian subject, especially delivery of the lithium (Li) ions to a body component for example across a body or tissue surface such as skin or a mucosal membrane, or for the delivery of the lithium ions directly to bodily fluids in a controllable and reproducible manner. In certain embodiments the device comprises a donor electrode that is a donor of the lithium ions; a protective architecture that is ionically conductive to the lithium ions, configured for application to a skin surface and positioned to isolate said donor electrode from the skin surface; and a counter electrode configured for application to the skin surface, where said counter electrode is operably coupled to said donor electrode.Type: GrantFiled: November 28, 2007Date of Patent: December 11, 2012Assignee: PolyPlus Battery CompanyInventors: Steven J. Visco, Yevgeniy S. Nimon, Bruce Katz
-
Publication number: 20120283099Abstract: The invention disclosed in this document concerns controlling planthoppers.Type: ApplicationFiled: May 4, 2012Publication date: November 8, 2012Applicant: DOW AGROSCIENCES LLCInventors: Agamananda Roy, Sanjoy Kundu, Suresh Ramachandran
-
Publication number: 20120282307Abstract: A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.Type: ApplicationFiled: July 19, 2012Publication date: November 8, 2012Applicant: Depomed, Inc.Inventors: Bret Berner, Sui Yuen Eddie Hou, Gloria M. Gusler
-
Patent number: 8303996Abstract: A barium sulfate-based powder is produced by bringing barium ions (A) into contact with sulfate ions (B) in the presence of one or more metallic ion species (C) selected from the group consisting of lithium ions, sodium ions, potassium ions, magnesium ions, calcium ions, zinc ions, and aluminum ions. Thus, barium sulfate-based powders having various characteristics and thus satisfying functional requirements for cosmetics can be obtained.Type: GrantFiled: March 7, 2002Date of Patent: November 6, 2012Assignee: Shiseido Company, Ltd.Inventors: Tsuyoshi Miyamoto, Katsuki Ogawa, Sadaki Takata, Mitsuhiro Denda
-
Publication number: 20120276168Abstract: The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized bu chemically conjugating amino acids to quetiapine. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.Type: ApplicationFiled: December 22, 2010Publication date: November 1, 2012Inventors: Travis Mickle, Sven Guenther, Sanjib Bera
-
Patent number: 8293285Abstract: A composition comprises an ion-exchanged carrageenan. The carrageenan may be a traditionally extracted or neutrally extracted iota or kappa carrageenan. The ion-exchanged carrageenan has reduced gelling cation contents, reduced gelling temperature, and reduced melting temperature, as compared to its non-ion-exchanged counterpart. The ion-exchanged carrageenan may be mixed with another carrageenan to form a carrageenan product having a unique gelling temperature and melting temperature. Also disclosed is a process for making an ion-exchanged carrageenan composition.Type: GrantFiled: March 12, 2009Date of Patent: October 23, 2012Assignee: CP Kelco U.S., Inc.Inventor: Jens Eskil Trudsoe
-
Publication number: 20120251450Abstract: Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell.Type: ApplicationFiled: April 4, 2011Publication date: October 4, 2012Inventors: Alex Punnoose, Denise Wingett
-
Patent number: 8273378Abstract: Dialysis solutions comprising pyrophosphates and methods of making and using the dialysis solutions are provided. In an embodiment, the present disclosure provides a dialysis solution comprising a stable and therapeutically effective amount of pyrophosphate. The dialysis solution can be sterilized, for example, using a technique such as autoclave, steam, high pressure, ultra-violet, filtration or combination thereof. The dialysis solution can be in the form of a concentrate.Type: GrantFiled: January 14, 2010Date of Patent: September 25, 2012Assignees: Baxter International, Inc., Baxter Healthcare S.A.Inventors: Bruce L. Riser, Paul Zieske, Sujatha Karoor, Himanshu D. Patel
-
Patent number: 8273364Abstract: A method for treating diseased plants, such as turf and trees, includes mixing a quantity of a plant remediation composition with water and applying the plant remediation composition to the diseased plants. The plant remediation composition may include from about 70 up to about 90 volume percent of a potassium silicate, up to 10 volume percent of a sodium silicate, from about 0.25 to about 3.0 volume percent of a surfactant, from about 0.25 to about 3.0 volume percent of a polyol, and the remaining volume percent water. The plant remediation composition may be used to treat plant molds, bacteria and fungi, such as Anthracnose, Fairy Ring, Brown Patch, Dollar Spot, and Snow Mold, and may also be used to prevent and remediate insect infestations.Type: GrantFiled: March 24, 2009Date of Patent: September 25, 2012Inventors: Louis Jack Norman, Kelly Green
-
Patent number: 8273380Abstract: A beverage for minimizing or reducing jet lag symptoms preferably includes vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin D, zinc, calcium, iodine, magnesium, manganese, ginseng, ginkgo biloba, grape seed extract, Echinacea extract and water. A method for minimizing or reducing jet lag symptoms including ingestion of the beverage by a traveler, one hour prior to a flight, and/or during the flight, and/or after a flight.Type: GrantFiled: May 19, 2009Date of Patent: September 25, 2012
-
Publication number: 20120237443Abstract: The present invention is directed to a novel poly (diol citrates)-based coating for implantable devices. More specifically, the specification describes methods and compositions for making and using implantable devices coated with citric acid copolymers or citric acid copolymers impregnated with therapeutic compositions and/or cells.Type: ApplicationFiled: December 6, 2011Publication date: September 20, 2012Applicant: Northwestern UniversityInventors: Guillermo Ameer, Jian Yang
-
Publication number: 20120237651Abstract: A method of reducing the contamination amount of mycotoxin in cereals wherein one or more compounds A selected from the group consisting of ammonium salts, primary to quaternary ammonium salts, alkali metal salts, alkaline earth metal salts and polyvalent metal salts of phosphorous acid and phosphite ester are given to the cereals.Type: ApplicationFiled: June 8, 2012Publication date: September 20, 2012Applicants: Hokusan Co., Ltd, Mitsui Chemicals Agro, Inc.Inventors: Daisuke Awakura, Kiyoshi Kimura, Kazuyoshi Masuda
-
Publication number: 20120231092Abstract: Treatment regimens for mood disorders that include administration of buprenorphine, alone or in combination with additional pharmacological agents are described. Specifically, treatment regimens that alleviate racing thoughts associated with bipolar disorder, and pharmaceutical compositions and kits for use therein are described. Dosing regimens, compositions, and kits including buprenorphine for treating mania associated with opioid withdrawal are also described.Type: ApplicationFiled: March 14, 2012Publication date: September 13, 2012Applicant: ComGenRx, Inc.Inventors: Bryan T. Oronsky, Neil C. Oronsky
-
Publication number: 20120231089Abstract: A method for reversing stress-induced dysfunctions of a human autonomic nervous system in accordance with Methylation Priority Principle includes repeatedly administering a methylation-promoting composition composed to promote a hierarchy of methylation functions of the Methylation Priority Principle including uninterrupted methylation cycle recycling of homocysteine to methionine, and uninterrupted processing and removal of metabolic products of stress.Type: ApplicationFiled: April 26, 2012Publication date: September 13, 2012Inventor: Alan Robert Vinitsky
-
Publication number: 20120219635Abstract: A bioactive tissue scaffold is fabricated from glass fiber that forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the pore space between the glass fiber in the porous matrix. Mechanical properties such as strength, elastic modulus, and pore size distribution is provided by the three-dimensional matrix that is formed by bonded overlapping and intertangled fibers. The bioactive tissue scaffold can be formed from raw materials that are not bioactive, but rather precursors to bioactive materials. The bioactive tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.Type: ApplicationFiled: May 3, 2011Publication date: August 30, 2012Applicant: BIO2 TECHNOLOGIES, INC.Inventor: James Jenq Liu
-
Publication number: 20120201908Abstract: The disclosure provides methods of treating bipolar disorder by administering an antiestrogen to reduce the severity and frequency of mood episodes. The disclosure further provides methods of treating depression with an antiestrogen in a descending dose protocol.Type: ApplicationFiled: August 12, 2010Publication date: August 9, 2012Applicant: Lunera Equities, LLLPInventor: Kirk Patrick Miller
-
Publication number: 20120195984Abstract: Described herein are compounds (including medical foods, pharmaceutical compositions, methods of compounding them), methods and systems for the diagnosis and/or treatment of prodromal schizophrenia. For example, described herein are methods of treating a developmentally-based neuropsychiatric disorder (schizophrenia) that includes first determining if a subject is at risk for such a disorder by examining phenotypical, serological immune markers and genotypical biomarkers. The biomarkers may be used to tailor the dose to be delivered by the medial food or pharmaceutical composition. Also described are compounds for treating prodromal (rather than full-blown) schizophrenia.Type: ApplicationFiled: February 2, 2012Publication date: August 2, 2012Inventor: Jay L. Lombard
-
Publication number: 20120195974Abstract: The invention disclosed in this document concerns controlling mealybugs.Type: ApplicationFiled: January 27, 2012Publication date: August 2, 2012Applicant: DOW AGROSCIENCES LLCInventors: Mayank Yadav, Suresh Ramachandran, Sanjoy Kundu
-
Publication number: 20120195985Abstract: The present invention provides compounds that are glycine transporter 1 (hereinafter referred to as GlyT-1) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of GlyT-1 such as cognitive disorders associated with Schizophrenia, ADHD (attention deficit hyperactivity disorder), MCI (mild cognitive impairment), and the like. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.Type: ApplicationFiled: March 21, 2012Publication date: August 2, 2012Applicant: Amgen Inc.Inventors: Stephen Hitchcock, Albert Amegadzie, Wenyuan Qian, Xiaoyang Xia, Scott S. Harried
-
Publication number: 20120189718Abstract: A pharmaceutical composition for dissolving and eliminating wart and excrescence consisting of protein is disclosed in the present invention. The pharmaceutical composition comprises (in 100 weight parts) 1.0-60.0 parts of sodium hydroxide and/or potassium hydroxide. The pharmaceutical composition further comprises 0.25-1.0 parts of tetracaine, bufalin, venenum bufonis and/or menthol having local anesthetic effect. The pharmaceutical composition can dissolve and eliminate wart and excrescence consisting of protein immediately and has significant effect and low side effect.Type: ApplicationFiled: June 7, 2010Publication date: July 26, 2012Inventors: Kuok Leong Tam, Io Cheng Tam, Io Man Tam
-
Publication number: 20120189709Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Debra L. Thomas, Pradip Mukerji
-
Publication number: 20120181230Abstract: The invention relates to the production of a concentrate for dialysis, the composition of which can be adapted individually to the respective needs of the patient. To do so, the special components required individually are added in the form of highly concentrated special concentrates with a volume of 10-500 mL to 3-10 liters of standard concentrate. The two solutions are then mixed thoroughly by compressed air, which is blown through the concentrate intake rod into the solution from a compressed air source in the dialysis machine.Type: ApplicationFiled: January 9, 2012Publication date: July 19, 2012Inventor: Peter Kloeffel
-
Publication number: 20120177750Abstract: Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.Type: ApplicationFiled: March 21, 2012Publication date: July 12, 2012Inventors: Gary S. HAHN, David O. Thueson
-
Publication number: 20120177744Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.Type: ApplicationFiled: January 11, 2012Publication date: July 12, 2012Applicant: ABBOTT LABORATORIESInventors: Debra L. Thomas, Pradip Mukerji
-
Publication number: 20120171156Abstract: Conventional commercial hair dyes form potent allergens and may also have irritant properties. If they were not already well established in the market and the side effects tolerated by consumers they would likely be deemed unsafe for use. The invention relates to compounds, compositions, formulations and methods for reducing, avoiding or eliminating allergic contact dermatitis reactions to conventional commercial hair dyes.Type: ApplicationFiled: June 17, 2010Publication date: July 5, 2012Inventors: David Basketter, John McFadden, Ian White
-
Publication number: 20120157976Abstract: The present invention generally relates to methods, compositions and materials for treatment of and promotion of neurological functional recovery from neurological conditions including central nervous system injuries and/or diseases.Type: ApplicationFiled: December 20, 2011Publication date: June 21, 2012Inventors: Stephen Davies, Kenneth Hal Minor
-
Publication number: 20120141598Abstract: The invention relates to a composition for decontaminating a toxin present in a polar or non-polar matrix. The composition includes (a) at least one activator that generates reactive oxygen species when reacted with an oxygen radical donator, and (b) at least one oxygen radical donator to react with the activator to create reactive oxygen species. The composition may also include one or more oxidizing agents that include reactive oxygen species.Type: ApplicationFiled: May 22, 2009Publication date: June 7, 2012Inventor: Jessie Kater
-
Publication number: 20120134919Abstract: A method for formation of spherical particles of ion substituted calcium phosphate. The method is based on precipitation of particles from a buffered solution under static, stirring or hydrothermal conditions. Also, the use of the formed materials and the particles in itself.Type: ApplicationFiled: August 4, 2010Publication date: May 31, 2012Applicant: BIOMATCELL ABInventors: Hakan Engqvist, Wei Xia
-
Publication number: 20120128735Abstract: A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.Type: ApplicationFiled: November 21, 2011Publication date: May 24, 2012Applicant: DEPOMED, INC.Inventors: Bret BERNER, Sui Yuen Eddie HOU
-
Publication number: 20120121731Abstract: A method for electrolytically generating a biocide having an electron deficient carrier fluid and chlorine dioxide, including providing a carrier fluid; providing a pair of electrodes interposed by a semi-permeable membrane within a vessel for creating a first passageway and a second passageway, an anode electrode of the pair of electrodes disposed in the first passageway, cathode electrode of the pair of electrodes disposed in the second passageway; flowing the carrier fluid through the vessel; applying an electric potential to the pair of electrodes to produce an oxidative acidic fluid, a reductive alkaline fluid, and anodic gases in the container; removing the fluids and gases from the vessel; mixing a portion of the anodic gases with the reductive alkaline fluid to produce a hypochlorite solution; and mixing a chlorite brine with the hypochlorite solution, followed by the introduction of additional oxidative acidic fluid to release the biocide.Type: ApplicationFiled: November 16, 2010Publication date: May 17, 2012Inventors: Michael J. Peters, David D. Faulder, John D. Breedlove, S. Robert Mayer
-
Publication number: 20120121724Abstract: The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin, as well as other therapeutic agents either with or without nitroglycerin, through the mucosal tissues of the oral cavity. The films include a water soluble film-forming polymer such as pullulan. Methods for producing the films are also disclosed.Type: ApplicationFiled: January 20, 2012Publication date: May 17, 2012Inventor: Todd Maibach
-
Publication number: 20120114743Abstract: Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.Type: ApplicationFiled: January 17, 2012Publication date: May 10, 2012Inventor: Keith Delprete
-
Patent number: 8173154Abstract: A method and compositions for wound care management comprising a dressing comprising a three-dimensional body of glass-based fibers comprising 40 to 80 weight % B2O3, wherein at least 25 wt. % of the fibers have a diameter between 200 nm and 4000 nm, and a length:width aspect ratio of at least 10. The glasses may also be used for wound care as fibers formed into sutures, as particles in surgical glue to close a wound, or as particles in an ointment or cream to apply to a wound. The compositions may comprise glass formers P2O5 and/or SiO2; alkali oxides selected from Li2O, Na2O, K2O, and Rb2O; and/or alkaline earth oxides selected from MgO, SrO, BaO and CaO. The compositions may further comprise 0.05 to 10 wt. % of one or more trace elements selected from Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn.Type: GrantFiled: January 6, 2010Date of Patent: May 8, 2012Assignee: The Curators of the University of MissouriInventors: Steven B. Jung, Delbert E. Day
-
Patent number: 8173175Abstract: The present invention consists of the discovery about an ammoniacal solution of sodium azide (NaN3) or other azide salts that in low concentrations induces the budding of grapevine buds and potentially other deciduous fruit trees with the same efficiency as H2CN2 makes.Type: GrantFiled: December 6, 2006Date of Patent: May 8, 2012Assignee: Universidad De ChileInventors: Francisco Javier Perez Correa, Juan Ormeno Nunez
-
Publication number: 20120107410Abstract: The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product.Type: ApplicationFiled: January 28, 2010Publication date: May 3, 2012Applicant: Industrial Farmaceutica Cantabria, S.A.Inventors: Marta Dominguez Valdes-Hevia, Aurora Brieva Delgado, Salvador Gonzalez Rodriguez, Eduardo Reyes Martin, Jose Carballeira Morado, Ernesto Quintana Gonzalez, Juan Pablo Pivel Ranieri, Antonio Guerrero Gomez-Pamo, Angeles Juarranz De La Fuente, Jesus Espada Regalado, Francisco Sanz Rodriguez
-
Publication number: 20120100230Abstract: Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, activities that can comprise and/or relate to, applying a treatment composition comprising or derived from a molecular matrix-residing chlorine dioxide composition.Type: ApplicationFiled: October 4, 2011Publication date: April 26, 2012Applicant: DHARMA IP, LLCInventors: Kenneth Harrison, Robert Cooke
-
Patent number: 8147855Abstract: Methods for inhibiting sensory responses in the skin such as pain and itch using topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle are disclosed.Type: GrantFiled: December 23, 2009Date of Patent: April 3, 2012Assignee: Cosmederm Bioscience, Inc.Inventors: Gary S. Hahn, David O. Thueson
-
Patent number: 8143309Abstract: A composition and method are described for sanitizing or otherwise treating a material such as a non-living surface, living tissue, soil or atmosphere which may be contaminated by a toxin, chemical warfare agent, insect, prion, microorganism or other infectious agent. The composition generally includes an aqueous composition mixture that includes: (a) lower alkanol; (b) an alkalinating agent, and (c) a fatty acid salt and/or ester. The components are present in an effective amount to sanitize (or treat) a material (or modifying a chemical contained thereon) to which the composition is applied. Also described are methods of making the composition.Type: GrantFiled: April 28, 2009Date of Patent: March 27, 2012Assignee: UrthTech, LLCInventor: Aziz C. Awad